LE PROJET PLUS
RÉDUIRE LA MORBIDITÉ ET LA MORTALITÉ DUES AU PALUDISME ET À L'ANÉMIE CHEZ LES ENFANTS DE MOINS DE 2 ANS
À PROPOS DU PROJET
The Plus Project is a 4.25-year Unitaid-funded project that will co-design, pilot, and evaluate country-adapted models of Perennial Malaria Chemoprevention (PMC) – the recent WHO recommendation which includes what was previously called Intermittent Preventive Treatment in infants (IPTi) using sulfadoxine-pyrimethamine (SP) in four focus countries: Benin, Cameroon, Cote d’Ivoire, and Mozambique. Underpinning these PMC pilots will be training, routine monitoring, supervision, and community engagement activities integrated into existing country systems.
The project is conducting a robust package of evaluations to generate evidence aimed at accelerating the adoption and scale-up of PMC in the project countries and other malaria-endemic countries of sub-Saharan Africa. Research studies include policy receptivity, process, impact, and economic evaluations, as well as SP suitability studies. The project is also conducting limited research in the Democratic Republic of the Congo, Ghana, and Zambia related to policy adoption, economic modeling, and SP resistance mapping to generate additional evidence for these countries and beyond.
The Plus Project will share learnings from implementation experience and research evidence to help countries decide if and how to use PMC as part of their malaria chemoprevention strategies. This includes supporting the PMC Community of Practice and rolling out a variety of external communications activities, such as quarterly bulletins, webinars, conference presentations, publications, and project website. The project has also helped to establish country advisory groups or technical working groups in project countries that are MoH-led and meet regularly to review PMC implementation and research progress, discuss challenges, and support the sustainability and scale of PMC.